Psoriasis and comorbid diseases Implications for management

被引：144
作者：
Takeshita, Junko [1 ,2 ]
Grewal, Sungat [1 ]
Langan, Sinead M. [4 ,5 ]
Mehta, Nehal N. [6 ]
Ogdie, Alexis [2 ,3 ]
Van Voorhers, Abby S. [7 ]
Gelfand, Joel M. [1 ,2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Div Rheumatol, Philadelphia, PA 19104 USA
[4] London Sch Hyg & Trop Med, London, England
[5] St Johns Inst Dermatol, London, England
[6] NHLBI, Bldg 10, Bethesda, MD 20892 USA
[7] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA 23501 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 03期
基金：
美国国家卫生研究院;
关键词：
cardiovascular disease; chronic kidney disease; comorbidities; Crohn's disease; depression; infection; lymphoma; metabolic syndrome; nonalcoholic fatty liver disease; psoriasis; psoriatic arthritis; screening; vaccination; POPULATION-BASED-COHORT; FACTOR-ALPHA THERAPY; CARDIOVASCULAR RISK-FACTORS; NECROSIS-FACTOR INHIBITORS; SQUAMOUS-CELL CARCINOMA; HEPATITIS-B-VIRUS; NATIONAL-PSORIASIS; RHEUMATOID-ARTHRITIS; BIOLOGIC THERAPY; TREATMENT RECOMMENDATIONS;
D O I：
10.1016/j.jaad.2016.07.065
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.
引用
收藏
页码：393 / 403
页数：11
相关论文
共 99 条
  • [71] Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists
    Parsi, Kory K.
    Brezinski, Elizabeth A.
    Lin, Tzu-Chun
    Li, Chin-Shang
    Armstrong, April W.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : 357 - 362
  • [72] EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    Peters, M. J. L.
    Symmons, D. P. M.
    McCarey, D.
    Dijkmans, B. A. C.
    Nicola, P.
    Kvien, T. K.
    McInnes, I. B.
    Haentzschel, H.
    Gonzalez-Gay, M. A.
    Provan, S.
    Semb, A.
    Sidiropoulos, P.
    Kitas, G.
    Smulders, Y. M.
    Soubrier, M.
    Szekanecz, Z.
    Sattar, N.
    Nurmohamed, M. T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 325 - 331
  • [73] Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
    Pouplard, C.
    Brenaut, E.
    Horreau, C.
    Barnetche, T.
    Misery, L.
    Richard, M. -A.
    Aractingi, S.
    Aubin, F.
    Cribier, B.
    Joly, P.
    Jullien, D.
    Le Maitre, M.
    Ortonne, J. -P.
    Paul, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 36 - 46
  • [74] Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis
    Prodanowich, S
    Ma, FC
    Taylor, JR
    Pezon, C
    Fasihi, T
    Kirsner, RS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) : 262 - 267
  • [75] Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
    Puig, L.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) : 1007 - 1011
  • [76] Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
    Ridker, Paul M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 332 - 339
  • [77] Treatment recommendations for psoriatic arthritis
    Ritchlin, C. T.
    Kavanaugh, A.
    Gladman, D. D.
    Mease, P. J.
    Helliwell, P.
    Boehncke, W-H
    de Vlam, K.
    Fiorentino, D.
    FitzGerald, O.
    Gottlieb, A. B.
    McHugh, N. J.
    Nash, P.
    Qureshi, A. A.
    Soriano, E. R.
    Taylor, W. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) : 1387 - 1394
  • [78] Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment
    Rosenberg, Peter
    Urwitz, Hanna
    Johannesson, Anders
    Ros, Anne-Marie
    Lindholm, Johan
    Kinnman, Nils
    Hultcrantz, Rolf
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1111 - 1118
  • [79] Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference
    Rosmarin, David M.
    Lebwohl, Mark
    Elewski, Boni E.
    Gottlieb, Alice B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (05) : 838 - 853
  • [80] The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
    Roubille, Camille
    Richer, Vincent
    Starnino, Tara
    McCourt, Collette
    McFarlane, Alexandra
    Fleming, Patrick
    Siu, Stephanie
    Kraft, John
    Lynde, Charles
    Pope, Janet
    Gulliver, Wayne
    Keeling, Stephanie
    Dutz, Jan
    Bessette, Louis
    Bissonnette, Robert
    Haraoui, Boulos
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 480 - 489
12345678910